SlideShare a Scribd company logo
ANTIPSYCHOTIC MEDICATIONS   Presented By: Jocelyn Aquino M.D.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Introduction of conventional antipsychotics - Synthesis of Chlorpromazine in 1950 - First clinical trial of Chlorpromazine for agitation and psychosis by Deniker, et al in 1952  - Classified as:  Phenothiazines (Clorpromazine) Piperazines (Perphenazine, Fluphenazine,   Trifluroperazine) Piperidines  (Thioridazine, Mesoridazine) Thioxanthenes (Thiothixine) Butyrophenones (Haloperidol) Dihydroindolines (Molindone) Diphenylbutylpiperidines (Pimozide)
Typical Antipsychotic
 
Mechanism of Action:  Blockade of D2 receptors  Mesolimbic Overactivity = Positive Symptoms of Psychosis
Mesolimbic Pathway Blocked = Diminished Positive Psychotic Symptoms
 
List and Characteristics of Conventional Antipsychotics
 
 
ExtraPyramidal Symptoms -  Acute Dystonic Reactions  with tightening of facial and   neck muscles, associated torticollis or retrotorticollis, with   or without tightness in the jaw  -  Akathisia  described as “restless legs” or the “need to keep   moving” -  Parkinsonism  characterized as flattening of the facial   expressions, stiffness of gait, muscular rigidity in the trunk   and extremities, pill rolling tremor of the fingers, and at   times excessive salivation Tardive Dyskinesia  chronic and often debilitating   rhythmic,   choreoathetoic movements, incidence is about 25% in   patients taking antipsychotic agents for 2 years, 50% of cases   are irreversible, 5-10x greater risk in older patients
Atypical Antipsychotic
Mechanism Of Action Of Atypical Antipsychotics - Blockade of D2 receptors - Serotonin dopamine antagonist - D4 receptor antagonist - D1 receptor antagonist - Dopamine partial agonist - 5HT3 receptor antagonist - 5HT2C antagonist - 5HT/NE neuronal reuptake
Subcortical region - increase dopamine activity = positive symptoms   Frontal cortex - low dopamine activity = negative symptoms
Correlation Between Pharmacologic Profile And Adverse Side Effects
Relative Advantages of Atypical Antipsychotics: - Fewer EPS due to blockade of D2 receptors and other receptors - Incidence of TD is improved  - Improvement of negative symptoms - Possible improvement of cognitive symptoms - Not need augmentation with anticholinergics  - Efficacy for mood and suicidality (Clozapine) - Efficacy for treatment-resistant patients (Clozapine) - Decrease relapse    Disadvantage of Atypical Antipsychotics: - Relatively more expensive  - Association with increased metabolic and cardiovascular risk
Factors to Consider in Selecting Which Medication  to Prescribe:  (The Risk Benefit Analysis Ratio)  Patient related factors:   - Prior history of similar episodes - Previous psychotropic drug treatment - Favorable and adverse response to any psychotropic   medications - Patient’s preference for a particular medication based   on past experience - Any medical condition or recent treatment with   medications for non-psychiatric illnesses - Past and present alcohol history - Use of over-the-counter or illicit drugs - Complexity of illness  - Co-morbidities –psychiatric and medical  - Illness burden  - Functional disability
Drug Related Factors: - FDA indications  - Adverse side effects  - Pharmacokinetic properties - Drug to drug interactions - Cost - Intended route of administration Most patients prefer oral medication. Patient with recurrent relapse related to non-adherence are candidates for long   acting injectable antipsychotic medication.
Assumptions: - All are equal in efficacy when dose is optimal. - Each have a unique SE profile. - Each have a unique pharmacokinetic properties. - Individual patients responds preferentially to   certain medication. - No patient characteristics predict response to   a particular medication
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Olanzapine (Zyprexa):Dose 10-30mg/d  Advantages:  - Wide range of receptor activity  - Half-life is 30 hours  - 5 hours to peak  - Available in disintegrating tablets (dissolves quickly,    difficult to cheek or spit out, comparable to   intramuscular injection, certainty of dosage)  - Injectable form 10mg vial (10mg/injection)    Disadvantages:  - Risk of weight gain  - Associated with diabetes and metabolic dyscontrol  - Sedation  - Orthostatic  - Anticholinegic effects
Quetiapine (Seroquel): Dose 100 -300 to 400-800mg/d  Advantages:  - Short elimination half-life (6 hours) given twice a day dose, works also once a day dose  - Lowest incidence of EPS  - Useful for psychosis in Parkinson’s Disease  - Rapid onset of action    Disadvantages:  - Only in tablet form  - More expensive  - Higher level of sedation even with gradual titration  - Orthostatic SE during early phase of treatment  - Risk of weight gain  - Akathisia  - Anticholinergic effects - Carries warning about potential development of cataracts
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Aripiprazole (Abilify): Dose 10-15mg up to 30mg/d Advantages: - Partial agonist at dopamine and serotonin receptors   (binds and activates but not same extent as a full agonist)  - 5HT1A receptor agonist activity  - 75 hours elimination half life  - Intermediate peak concentration  - Relatively low incidence of EPS  - Recent indication for Bipolar patients  - Injectable IM 10 and 15mg    Disadvantages:   - SE: nausea, vomiting, insomnia, headache  - Not a lot of clinical experience
Selected Side Effects Of Commonly Used Antipsychotic Medications
Pharmacologic Profile Of Some Antipsychotics
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Medical Comorbilities - Diabetes and Obesity is reported to be 1.5 - 2 times higher in  people with Affective Disorders and Schizophrenia   compared with the general population. - People with chronic mental illness have increased morbidity   and mortality from natural causes compared with the general population. - They have 15% to 20% lower life expectancy.  Characteristics of Individuals with Chronic Mental Illness - Medically underserved - Sedentary behavior - Excessive sleeping - Overeating - Poor Nutrition - Substance Abuse (47%) - Smoking  (75% vs 25%)
Based on Consensus Statement, Diabetes Care 2004 Feb:27 (2) 596-601
Source: Based on Toalson Pet al Primary Care Companion Journal of Clinical Psychiatry 2004;6:152-158
From the American Diabetic Association, American Psychiatric Association, American Association of Clinical Endocrinologist and the North American Association for the study of Obesity Source: Based on consensus statement, Diabetic Care 2004 Feb 27 (2); 596-601
Increased Mortality In Elderly Patients With Dementia Related Psychosis :   Elderly patients with dementia related psychosis treated with atypical antipsychotic drugs are at an increased risk of death compared to placebo. Analysis of 17 placebo controlled trials (modal duration of 10 weeks) in this patients revealed a risk of death in the drug treated patients of between 1.6 to 1.7 times seen in placebo treated patients.  Over the course of a typical 10-week controlled trial, the rate of death in drug treated patients was about 4.5% compared to a rate of 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g. heart failure, sudden death) or infectious (e.g. pneumonia) in nature.
Neurleptic Malignant Syndrome  - life threatening, occurs in about 0.5%-1% of patients treated with antipsychotic, more frequent in conventional high potency agents, occurs in atypicals as well. Cardinal Signs and Symptoms  - include body temperature exceeding 38*C, altered level of consciousness, tachycardia, labile blood pressure, diaphoresis and extreme muscle rigidity Elevated CPK > 300U/ml, Elevated WBC>15,000/mm3 Treatment  - discontinuation of antipsychotics and supportive
Choice Of Medication In The Acute Phase Of Schizophrenia
Antipsychotic Algorhythm
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Goals of Treatment: - Reduce acute symptoms  - Improve long term course - Avoid relapse
Areas Of Neurocognitive Dysfunction In Schizophrenia ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Improvement In Cognition ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Psychosocial Interventions ,[object Object],[object Object],[object Object],[object Object],[object Object]
Chemical Targets For Cognitive Therapy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Antipsychotic Drug Interactions:
Addition of inhibitors of CYP3A4 and 1A2 isozymes such as    erythromycin and fluvoxamine can elevate clozapine serum   concentration to toxic levels.  Carbamazepine, phenobarbital and phenytoin – induce   metabolism of antipsychotic agents , thereby lowering serum   concentrations below a therapeutic threshold.
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Summary ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Conclusion
References: - APA Practice Guideline for Treatment of Psychiatric Disorders   Compendium 2004 - Essentials of Clinical Psychiatry 2004 - Handbook of Drug Therapy in Psychiatry 3 rd  edition  - Practical Guide to Care of Psychiatric Patients 3 rd  edition - Essential Psychopharmacology Neuroscientific Basis and Practical   Applications by Stephen M. Stahl - Medical Comorbidity in Patients with Schizophrenia, Journal of   Clinical Psychiatry Supplement 6 Vol 66, Nasrallah,Keck 2005 - New Findings in Schizophrenia: An Update on Causes and   Treatment, Supplement to Clinical Psychiatry News,   Nemeroff, Lieberman et al 2004 Other resources: APA Practice Guideline http://www.psych.org/psych_pract/treatg/pg/prac_guide.cfm
VERSION: Edited: 02112006

More Related Content

What's hot

Atypical antipsychotics
Atypical antipsychoticsAtypical antipsychotics
Atypical antipsychotics
Murugavel Veeramani
 
Ketamine - clinical use in major depression - Mats Lindström - SSAI2017
Ketamine - clinical use in major depression - Mats Lindström - SSAI2017Ketamine - clinical use in major depression - Mats Lindström - SSAI2017
Ketamine - clinical use in major depression - Mats Lindström - SSAI2017
scanFOAM
 
Anti psychotics
Anti psychoticsAnti psychotics
Anti psychotics
Malek Azar
 
Long acting antipsychotics
Long acting antipsychoticsLong acting antipsychotics
Long acting antipsychotics
Dr.Jeet Nadpara
 
Antipsychotic drugs
Antipsychotic drugsAntipsychotic drugs
Antipsychotic drugs
Fadzlina Zabri
 
Antipsychotic drug
Antipsychotic drug Antipsychotic drug
Antipsychotic drug
Vibha Manu
 
Antipsychotics and updates
Antipsychotics and updatesAntipsychotics and updates
Antipsychotics and updates
Jyoti Sharma
 
Antipsychotics - Pharmacology
Antipsychotics - PharmacologyAntipsychotics - Pharmacology
Antipsychotics - Pharmacology
Areej Abu Hanieh
 
Classical versus atypical antipsychotics
Classical  versus  atypical antipsychoticsClassical  versus  atypical antipsychotics
Classical versus atypical antipsychotics
Akhil Joseph
 
Behavioral and psychological symptoms of dementia
Behavioral and psychological symptoms of dementiaBehavioral and psychological symptoms of dementia
Behavioral and psychological symptoms of dementia
Roopchand Ps
 
Atypical antipsychotics
Atypical antipsychoticsAtypical antipsychotics
Atypical antipsychotics
Karrar Husain
 
Neurocognetive disorder due to hiv, vascular and other medical conditions
Neurocognetive disorder due to hiv, vascular and other medical conditionsNeurocognetive disorder due to hiv, vascular and other medical conditions
Neurocognetive disorder due to hiv, vascular and other medical conditions
Shünün G. Abrha
 
Mood stabilizers
Mood stabilizersMood stabilizers
Mood stabilizers
Praveen Goonathilake
 
Major Depressive Disorder
Major Depressive Disorder Major Depressive Disorder
Major Depressive Disorder
Usman Amin
 
Major Depressive Disorder (MDD)
Major Depressive Disorder (MDD)Major Depressive Disorder (MDD)
Major Depressive Disorder (MDD)
Arwa M. Amin
 
Schizophrenia and Antipsychotic Drugs
Schizophrenia and Antipsychotic DrugsSchizophrenia and Antipsychotic Drugs
Schizophrenia and Antipsychotic Drugs
FarazaJaved
 
Pharmacotherapy of parkinsons disease
Pharmacotherapy of parkinsons diseasePharmacotherapy of parkinsons disease
Pharmacotherapy of parkinsons disease
Qudsia Nuzhat
 

What's hot (20)

Atypical antipsychotics
Atypical antipsychoticsAtypical antipsychotics
Atypical antipsychotics
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Ketamine - clinical use in major depression - Mats Lindström - SSAI2017
Ketamine - clinical use in major depression - Mats Lindström - SSAI2017Ketamine - clinical use in major depression - Mats Lindström - SSAI2017
Ketamine - clinical use in major depression - Mats Lindström - SSAI2017
 
Anti psychotics
Anti psychoticsAnti psychotics
Anti psychotics
 
Long acting antipsychotics
Long acting antipsychoticsLong acting antipsychotics
Long acting antipsychotics
 
Antipsychotic drugs
Antipsychotic drugsAntipsychotic drugs
Antipsychotic drugs
 
Antipsyc
AntipsycAntipsyc
Antipsyc
 
Antipsychotic drug
Antipsychotic drug Antipsychotic drug
Antipsychotic drug
 
Antipsychotics and updates
Antipsychotics and updatesAntipsychotics and updates
Antipsychotics and updates
 
Antipsychotics - Pharmacology
Antipsychotics - PharmacologyAntipsychotics - Pharmacology
Antipsychotics - Pharmacology
 
Classical versus atypical antipsychotics
Classical  versus  atypical antipsychoticsClassical  versus  atypical antipsychotics
Classical versus atypical antipsychotics
 
Behavioral and psychological symptoms of dementia
Behavioral and psychological symptoms of dementiaBehavioral and psychological symptoms of dementia
Behavioral and psychological symptoms of dementia
 
Atypical antipsychotics
Atypical antipsychoticsAtypical antipsychotics
Atypical antipsychotics
 
Neurocognetive disorder due to hiv, vascular and other medical conditions
Neurocognetive disorder due to hiv, vascular and other medical conditionsNeurocognetive disorder due to hiv, vascular and other medical conditions
Neurocognetive disorder due to hiv, vascular and other medical conditions
 
Mood stabilizers
Mood stabilizersMood stabilizers
Mood stabilizers
 
Major Depressive Disorder
Major Depressive Disorder Major Depressive Disorder
Major Depressive Disorder
 
Mood stabilizers
Mood stabilizersMood stabilizers
Mood stabilizers
 
Major Depressive Disorder (MDD)
Major Depressive Disorder (MDD)Major Depressive Disorder (MDD)
Major Depressive Disorder (MDD)
 
Schizophrenia and Antipsychotic Drugs
Schizophrenia and Antipsychotic DrugsSchizophrenia and Antipsychotic Drugs
Schizophrenia and Antipsychotic Drugs
 
Pharmacotherapy of parkinsons disease
Pharmacotherapy of parkinsons diseasePharmacotherapy of parkinsons disease
Pharmacotherapy of parkinsons disease
 

Viewers also liked

Antipsychotic : Dr Rahul Kunkulol's Power point preparations
Antipsychotic : Dr Rahul Kunkulol's Power point preparationsAntipsychotic : Dr Rahul Kunkulol's Power point preparations
Antipsychotic : Dr Rahul Kunkulol's Power point preparations
Rahul Kunkulol
 
Pharmacological guidelines in the treatment of schizophrenia
Pharmacological guidelines in the treatment of schizophreniaPharmacological guidelines in the treatment of schizophrenia
Pharmacological guidelines in the treatment of schizophrenia
ehab elbaz
 
anti-psychotic drugs
anti-psychotic drugsanti-psychotic drugs
anti-psychotic drugs
DJ CrissCross
 
Antipsychotics - drdhriti
Antipsychotics - drdhritiAntipsychotics - drdhriti
Antipsychotics - drdhriti
http://neigrihms.gov.in/
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychoticsraj kumar
 
Psychiatric medication paec november 2013
Psychiatric medication paec november 2013Psychiatric medication paec november 2013
Psychiatric medication paec november 2013discoverccs-org
 
Psychiatric medication and its importance
Psychiatric  medication and its importancePsychiatric  medication and its importance
Psychiatric medication and its importance
lakshmi189
 
Management of schizophrenia dr. p a khan
Management of schizophrenia dr. p a khanManagement of schizophrenia dr. p a khan
Management of schizophrenia dr. p a khan
Dr. Parvaiz A Khan
 
Side effects of Antipsychotic Agents
Side effects of Antipsychotic AgentsSide effects of Antipsychotic Agents
Polypharmacy+in+Schizophrenia
Polypharmacy+in+SchizophreniaPolypharmacy+in+Schizophrenia
Polypharmacy+in+Schizophreniadhavalshah4424
 
Antisychotic Drugs
Antisychotic DrugsAntisychotic Drugs
Antisychotic Drugs
Bhudev Global
 
Antidepressant drugs
Antidepressant drugsAntidepressant drugs
Antidepressant drugs
Amira Badr
 
The Pharmacology of Beta-Blockers
The Pharmacology of Beta-BlockersThe Pharmacology of Beta-Blockers
The Pharmacology of Beta-BlockersPrijay Bakrania
 
Neuroleptics (antipsychotics)
Neuroleptics (antipsychotics)Neuroleptics (antipsychotics)
Neuroleptics (antipsychotics)
Mohsin Aziz
 
Antipsychotics, antipsychotic drugs, major tranquilizers, tranquilizers
Antipsychotics, antipsychotic drugs, major tranquilizers, tranquilizersAntipsychotics, antipsychotic drugs, major tranquilizers, tranquilizers
Antipsychotics, antipsychotic drugs, major tranquilizers, tranquilizers
Muthu Venkatachalam
 
Typical antipsychotics
Typical   antipsychoticsTypical   antipsychotics
Typical antipsychotics
Anant Rathi
 

Viewers also liked (20)

Antipsychotic : Dr Rahul Kunkulol's Power point preparations
Antipsychotic : Dr Rahul Kunkulol's Power point preparationsAntipsychotic : Dr Rahul Kunkulol's Power point preparations
Antipsychotic : Dr Rahul Kunkulol's Power point preparations
 
Pharmacological guidelines in the treatment of schizophrenia
Pharmacological guidelines in the treatment of schizophreniaPharmacological guidelines in the treatment of schizophrenia
Pharmacological guidelines in the treatment of schizophrenia
 
anti-psychotic drugs
anti-psychotic drugsanti-psychotic drugs
anti-psychotic drugs
 
Antipsychotics - drdhriti
Antipsychotics - drdhritiAntipsychotics - drdhriti
Antipsychotics - drdhriti
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Antipsychotic drugs
Antipsychotic drugsAntipsychotic drugs
Antipsychotic drugs
 
Pharma report
Pharma reportPharma report
Pharma report
 
Psychiatric medication paec november 2013
Psychiatric medication paec november 2013Psychiatric medication paec november 2013
Psychiatric medication paec november 2013
 
Psychiatric medication and its importance
Psychiatric  medication and its importancePsychiatric  medication and its importance
Psychiatric medication and its importance
 
Management of schizophrenia dr. p a khan
Management of schizophrenia dr. p a khanManagement of schizophrenia dr. p a khan
Management of schizophrenia dr. p a khan
 
Conventional
ConventionalConventional
Conventional
 
Side effects of Antipsychotic Agents
Side effects of Antipsychotic AgentsSide effects of Antipsychotic Agents
Side effects of Antipsychotic Agents
 
Polypharmacy+in+Schizophrenia
Polypharmacy+in+SchizophreniaPolypharmacy+in+Schizophrenia
Polypharmacy+in+Schizophrenia
 
Antisychotic Drugs
Antisychotic DrugsAntisychotic Drugs
Antisychotic Drugs
 
Beta blockers dr wan azizi
Beta blockers dr wan aziziBeta blockers dr wan azizi
Beta blockers dr wan azizi
 
Antidepressant drugs
Antidepressant drugsAntidepressant drugs
Antidepressant drugs
 
The Pharmacology of Beta-Blockers
The Pharmacology of Beta-BlockersThe Pharmacology of Beta-Blockers
The Pharmacology of Beta-Blockers
 
Neuroleptics (antipsychotics)
Neuroleptics (antipsychotics)Neuroleptics (antipsychotics)
Neuroleptics (antipsychotics)
 
Antipsychotics, antipsychotic drugs, major tranquilizers, tranquilizers
Antipsychotics, antipsychotic drugs, major tranquilizers, tranquilizersAntipsychotics, antipsychotic drugs, major tranquilizers, tranquilizers
Antipsychotics, antipsychotic drugs, major tranquilizers, tranquilizers
 
Typical antipsychotics
Typical   antipsychoticsTypical   antipsychotics
Typical antipsychotics
 

Similar to Test

GROUP NO 6 PPT.pptx
GROUP NO 6 PPT.pptxGROUP NO 6 PPT.pptx
GROUP NO 6 PPT.pptx
ShumailaQadir2
 
Management of schizophrenia
Management of schizophreniaManagement of schizophrenia
Management of schizophrenia
Yasser Alzainy
 
Antipsychotic Drugs "Typical and Atypical"
Antipsychotic Drugs "Typical and Atypical" Antipsychotic Drugs "Typical and Atypical"
Antipsychotic Drugs "Typical and Atypical"
Sawsan Aboul-Fotouh
 
Psychopharmacology in elderly
Psychopharmacology in elderlyPsychopharmacology in elderly
Psychopharmacology in elderly
Ravi Soni
 
Adverse Drug Reactions
Adverse Drug Reactions Adverse Drug Reactions
Adverse Drug Reactions
Dr. Pawan Kumar B
 
Medications in the elderly
Medications in the elderlyMedications in the elderly
Medications in the elderly
http://neigrihms.gov.in/
 
Pharmacological treatment of schizophrenia
Pharmacological treatment of schizophreniaPharmacological treatment of schizophrenia
Pharmacological treatment of schizophrenia
joanna1956
 
Antidepressants mood_stabilizers
Antidepressants  mood_stabilizersAntidepressants  mood_stabilizers
Antidepressants mood_stabilizersUniversity of Miami
 
Palazidou 03
Palazidou 03Palazidou 03
Palazidou 03henkpar
 
Anti depressants and mood stabilizers
Anti depressants and mood stabilizersAnti depressants and mood stabilizers
Anti depressants and mood stabilizersUniversity of Miami
 
The essentials of psychopharmacology.ppt
The essentials of psychopharmacology.pptThe essentials of psychopharmacology.ppt
The essentials of psychopharmacology.ppt
AkshayNaik919607
 
Anti depressent drugs
Anti depressent drugsAnti depressent drugs
Anti depressent drugs
alaa salem
 
Adverse drug reaction sjk
Adverse drug reaction sjkAdverse drug reaction sjk
Adverse drug reaction sjk
shailajakamble3
 
Drug interctions in psychiatry
Drug interctions in psychiatryDrug interctions in psychiatry
Drug interctions in psychiatry
Deepika Bansal
 
Antidepressant_Pharmacology.ppt
Antidepressant_Pharmacology.pptAntidepressant_Pharmacology.ppt
Antidepressant_Pharmacology.ppt
AmanDeepTiwari4
 
Antidepressant_Pharmacology.ppt
Antidepressant_Pharmacology.pptAntidepressant_Pharmacology.ppt
Antidepressant_Pharmacology.ppt
ssuserc71950
 
Antidepressant_Pharmacology.ppt
Antidepressant_Pharmacology.pptAntidepressant_Pharmacology.ppt
Antidepressant_Pharmacology.ppt
Imtiyaz60
 
Antidepressant_Pharmacology.ppt
Antidepressant_Pharmacology.pptAntidepressant_Pharmacology.ppt
Antidepressant_Pharmacology.ppt
prince1123
 
Meds For Pain And Inflammation
Meds For Pain And InflammationMeds For Pain And Inflammation
Meds For Pain And Inflammationpmrjulio
 

Similar to Test (20)

GROUP NO 6 PPT.pptx
GROUP NO 6 PPT.pptxGROUP NO 6 PPT.pptx
GROUP NO 6 PPT.pptx
 
Management of schizophrenia
Management of schizophreniaManagement of schizophrenia
Management of schizophrenia
 
Antipsychotic Drugs "Typical and Atypical"
Antipsychotic Drugs "Typical and Atypical" Antipsychotic Drugs "Typical and Atypical"
Antipsychotic Drugs "Typical and Atypical"
 
Psychopharmacology in elderly
Psychopharmacology in elderlyPsychopharmacology in elderly
Psychopharmacology in elderly
 
Adverse Drug Reactions
Adverse Drug Reactions Adverse Drug Reactions
Adverse Drug Reactions
 
Medications in the elderly
Medications in the elderlyMedications in the elderly
Medications in the elderly
 
Pharmacological treatment of schizophrenia
Pharmacological treatment of schizophreniaPharmacological treatment of schizophrenia
Pharmacological treatment of schizophrenia
 
Antidepressants mood_stabilizers
Antidepressants  mood_stabilizersAntidepressants  mood_stabilizers
Antidepressants mood_stabilizers
 
Palazidou 03
Palazidou 03Palazidou 03
Palazidou 03
 
Sedation
SedationSedation
Sedation
 
Anti depressants and mood stabilizers
Anti depressants and mood stabilizersAnti depressants and mood stabilizers
Anti depressants and mood stabilizers
 
The essentials of psychopharmacology.ppt
The essentials of psychopharmacology.pptThe essentials of psychopharmacology.ppt
The essentials of psychopharmacology.ppt
 
Anti depressent drugs
Anti depressent drugsAnti depressent drugs
Anti depressent drugs
 
Adverse drug reaction sjk
Adverse drug reaction sjkAdverse drug reaction sjk
Adverse drug reaction sjk
 
Drug interctions in psychiatry
Drug interctions in psychiatryDrug interctions in psychiatry
Drug interctions in psychiatry
 
Antidepressant_Pharmacology.ppt
Antidepressant_Pharmacology.pptAntidepressant_Pharmacology.ppt
Antidepressant_Pharmacology.ppt
 
Antidepressant_Pharmacology.ppt
Antidepressant_Pharmacology.pptAntidepressant_Pharmacology.ppt
Antidepressant_Pharmacology.ppt
 
Antidepressant_Pharmacology.ppt
Antidepressant_Pharmacology.pptAntidepressant_Pharmacology.ppt
Antidepressant_Pharmacology.ppt
 
Antidepressant_Pharmacology.ppt
Antidepressant_Pharmacology.pptAntidepressant_Pharmacology.ppt
Antidepressant_Pharmacology.ppt
 
Meds For Pain And Inflammation
Meds For Pain And InflammationMeds For Pain And Inflammation
Meds For Pain And Inflammation
 

Recently uploaded

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 

Recently uploaded (20)

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 

Test

  • 1. ANTIPSYCHOTIC MEDICATIONS Presented By: Jocelyn Aquino M.D.
  • 2.
  • 3. Introduction of conventional antipsychotics - Synthesis of Chlorpromazine in 1950 - First clinical trial of Chlorpromazine for agitation and psychosis by Deniker, et al in 1952 - Classified as: Phenothiazines (Clorpromazine) Piperazines (Perphenazine, Fluphenazine, Trifluroperazine) Piperidines (Thioridazine, Mesoridazine) Thioxanthenes (Thiothixine) Butyrophenones (Haloperidol) Dihydroindolines (Molindone) Diphenylbutylpiperidines (Pimozide)
  • 5.  
  • 6. Mechanism of Action: Blockade of D2 receptors Mesolimbic Overactivity = Positive Symptoms of Psychosis
  • 7. Mesolimbic Pathway Blocked = Diminished Positive Psychotic Symptoms
  • 8.  
  • 9. List and Characteristics of Conventional Antipsychotics
  • 10.  
  • 11.  
  • 12. ExtraPyramidal Symptoms - Acute Dystonic Reactions with tightening of facial and neck muscles, associated torticollis or retrotorticollis, with or without tightness in the jaw - Akathisia described as “restless legs” or the “need to keep moving” - Parkinsonism characterized as flattening of the facial expressions, stiffness of gait, muscular rigidity in the trunk and extremities, pill rolling tremor of the fingers, and at times excessive salivation Tardive Dyskinesia chronic and often debilitating rhythmic, choreoathetoic movements, incidence is about 25% in patients taking antipsychotic agents for 2 years, 50% of cases are irreversible, 5-10x greater risk in older patients
  • 14. Mechanism Of Action Of Atypical Antipsychotics - Blockade of D2 receptors - Serotonin dopamine antagonist - D4 receptor antagonist - D1 receptor antagonist - Dopamine partial agonist - 5HT3 receptor antagonist - 5HT2C antagonist - 5HT/NE neuronal reuptake
  • 15. Subcortical region - increase dopamine activity = positive symptoms Frontal cortex - low dopamine activity = negative symptoms
  • 16. Correlation Between Pharmacologic Profile And Adverse Side Effects
  • 17. Relative Advantages of Atypical Antipsychotics: - Fewer EPS due to blockade of D2 receptors and other receptors - Incidence of TD is improved - Improvement of negative symptoms - Possible improvement of cognitive symptoms - Not need augmentation with anticholinergics - Efficacy for mood and suicidality (Clozapine) - Efficacy for treatment-resistant patients (Clozapine) - Decrease relapse   Disadvantage of Atypical Antipsychotics: - Relatively more expensive - Association with increased metabolic and cardiovascular risk
  • 18. Factors to Consider in Selecting Which Medication to Prescribe: (The Risk Benefit Analysis Ratio) Patient related factors: - Prior history of similar episodes - Previous psychotropic drug treatment - Favorable and adverse response to any psychotropic medications - Patient’s preference for a particular medication based on past experience - Any medical condition or recent treatment with medications for non-psychiatric illnesses - Past and present alcohol history - Use of over-the-counter or illicit drugs - Complexity of illness - Co-morbidities –psychiatric and medical - Illness burden - Functional disability
  • 19. Drug Related Factors: - FDA indications - Adverse side effects - Pharmacokinetic properties - Drug to drug interactions - Cost - Intended route of administration Most patients prefer oral medication. Patient with recurrent relapse related to non-adherence are candidates for long acting injectable antipsychotic medication.
  • 20. Assumptions: - All are equal in efficacy when dose is optimal. - Each have a unique SE profile. - Each have a unique pharmacokinetic properties. - Individual patients responds preferentially to certain medication. - No patient characteristics predict response to a particular medication
  • 21.
  • 22.
  • 23. Olanzapine (Zyprexa):Dose 10-30mg/d Advantages: - Wide range of receptor activity - Half-life is 30 hours - 5 hours to peak - Available in disintegrating tablets (dissolves quickly, difficult to cheek or spit out, comparable to intramuscular injection, certainty of dosage) - Injectable form 10mg vial (10mg/injection)   Disadvantages: - Risk of weight gain - Associated with diabetes and metabolic dyscontrol - Sedation - Orthostatic - Anticholinegic effects
  • 24. Quetiapine (Seroquel): Dose 100 -300 to 400-800mg/d Advantages: - Short elimination half-life (6 hours) given twice a day dose, works also once a day dose - Lowest incidence of EPS - Useful for psychosis in Parkinson’s Disease - Rapid onset of action   Disadvantages: - Only in tablet form - More expensive - Higher level of sedation even with gradual titration - Orthostatic SE during early phase of treatment - Risk of weight gain - Akathisia - Anticholinergic effects - Carries warning about potential development of cataracts
  • 25.
  • 26.  
  • 27. Aripiprazole (Abilify): Dose 10-15mg up to 30mg/d Advantages: - Partial agonist at dopamine and serotonin receptors (binds and activates but not same extent as a full agonist) - 5HT1A receptor agonist activity - 75 hours elimination half life - Intermediate peak concentration - Relatively low incidence of EPS - Recent indication for Bipolar patients - Injectable IM 10 and 15mg   Disadvantages: - SE: nausea, vomiting, insomnia, headache - Not a lot of clinical experience
  • 28. Selected Side Effects Of Commonly Used Antipsychotic Medications
  • 29. Pharmacologic Profile Of Some Antipsychotics
  • 30.
  • 31. Medical Comorbilities - Diabetes and Obesity is reported to be 1.5 - 2 times higher in people with Affective Disorders and Schizophrenia compared with the general population. - People with chronic mental illness have increased morbidity and mortality from natural causes compared with the general population. - They have 15% to 20% lower life expectancy. Characteristics of Individuals with Chronic Mental Illness - Medically underserved - Sedentary behavior - Excessive sleeping - Overeating - Poor Nutrition - Substance Abuse (47%) - Smoking (75% vs 25%)
  • 32. Based on Consensus Statement, Diabetes Care 2004 Feb:27 (2) 596-601
  • 33. Source: Based on Toalson Pet al Primary Care Companion Journal of Clinical Psychiatry 2004;6:152-158
  • 34. From the American Diabetic Association, American Psychiatric Association, American Association of Clinical Endocrinologist and the North American Association for the study of Obesity Source: Based on consensus statement, Diabetic Care 2004 Feb 27 (2); 596-601
  • 35. Increased Mortality In Elderly Patients With Dementia Related Psychosis : Elderly patients with dementia related psychosis treated with atypical antipsychotic drugs are at an increased risk of death compared to placebo. Analysis of 17 placebo controlled trials (modal duration of 10 weeks) in this patients revealed a risk of death in the drug treated patients of between 1.6 to 1.7 times seen in placebo treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug treated patients was about 4.5% compared to a rate of 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g. heart failure, sudden death) or infectious (e.g. pneumonia) in nature.
  • 36. Neurleptic Malignant Syndrome - life threatening, occurs in about 0.5%-1% of patients treated with antipsychotic, more frequent in conventional high potency agents, occurs in atypicals as well. Cardinal Signs and Symptoms - include body temperature exceeding 38*C, altered level of consciousness, tachycardia, labile blood pressure, diaphoresis and extreme muscle rigidity Elevated CPK > 300U/ml, Elevated WBC>15,000/mm3 Treatment - discontinuation of antipsychotics and supportive
  • 37. Choice Of Medication In The Acute Phase Of Schizophrenia
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.  
  • 46. Addition of inhibitors of CYP3A4 and 1A2 isozymes such as erythromycin and fluvoxamine can elevate clozapine serum concentration to toxic levels. Carbamazepine, phenobarbital and phenytoin – induce metabolism of antipsychotic agents , thereby lowering serum concentrations below a therapeutic threshold.
  • 47.  
  • 48.
  • 49.
  • 50.
  • 51. References: - APA Practice Guideline for Treatment of Psychiatric Disorders Compendium 2004 - Essentials of Clinical Psychiatry 2004 - Handbook of Drug Therapy in Psychiatry 3 rd edition - Practical Guide to Care of Psychiatric Patients 3 rd edition - Essential Psychopharmacology Neuroscientific Basis and Practical Applications by Stephen M. Stahl - Medical Comorbidity in Patients with Schizophrenia, Journal of Clinical Psychiatry Supplement 6 Vol 66, Nasrallah,Keck 2005 - New Findings in Schizophrenia: An Update on Causes and Treatment, Supplement to Clinical Psychiatry News, Nemeroff, Lieberman et al 2004 Other resources: APA Practice Guideline http://www.psych.org/psych_pract/treatg/pg/prac_guide.cfm